Dysfunctional cell-cell signaling in the neurovascular unit as a paradigm for central nervous system disease.
about
Vasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and InterventionsFate of graft cells: what should be clarified for development of mesenchymal stem cell therapy for ischemic stroke?The blood-spinal cord barrier: morphology and clinical implicationsLinolenic acid provides multi-cellular protective effects after photothrombotic cerebral ischemia in ratsNeurovascular pathways to neurodegeneration in Alzheimer's disease and other disordersMorphine increases hippocampal viral load and suppresses frontal lobe CCL5 expression in the LP-BM5 AIDS modelAngiogenesis, neurogenesis and brain recovery of function following injuryNOSH-NBP, a Novel Nitric Oxide and Hydrogen Sulfide- Releasing Hybrid, Attenuates Ischemic Stroke-Induced Neuroinflammatory Injury by Modulating Microglia PolarizationMolecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activatorThe vasculome of the mouse brain.Loss of cerebral cavernous malformation 3 (Ccm3) in neuroglia leads to CCM and vascular pathology.Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease.Regulation of neurovascular coupling in autoimmunity to water and ion channelsDecreased cerebrovascular brain-derived neurotrophic factor-mediated neuroprotection in the diabetic brain.Inhibition of phosphatase and tensin homolog deleted on chromosome 10 decreases rat cortical neuron injury and blood-brain barrier permeability, and improves neurological functional recovery in traumatic brain injury model.Hypoxia inducible factor-1alpha mediates protection of DL-3-n-butylphthalide in brain microvascular endothelial cells against oxygen glucose deprivation-induced injury.Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease17β-Estradiol prevents cell death and mitochondrial dysfunction by an estrogen receptor-dependent mechanism in astrocytes after oxygen-glucose deprivation/reperfusion.The neurovascular unit and combination treatment strategies for strokec-Src-dependent EGF receptor transactivation contributes to ET-1-induced COX-2 expression in brain microvascular endothelial cellsNeurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.Age-related decrease in cerebrovascular-derived neuroprotective proteins: effect of acetaminophenCytoprotective protein C pathways and implications for stroke and neurological disordersVascular neuroprotection via TrkB- and Akt-dependent cell survival signaling.Up-regulation of COX-2/PGE2 by endothelin-1 via MAPK-dependent NF-κB pathway in mouse brain microvascular endothelial cellsCompliant head probe for positioning electroencephalography electrodes and near-infrared spectroscopy optodes.Neuroprotective effects of estrogens following ischemic stroke.Stroke-related translational research.VEGF-A165 potently induces human blood-nerve barrier endothelial cell proliferation, angiogenesis, and wound healing in vitro.Prostacyclin promotes oligodendrocyte precursor recruitment and remyelination after spinal cord demyelinationAn oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells.Oligovascular signaling in white matter stroke.Controversies and evolving new mechanisms in subarachnoid hemorrhage.Inhibition of autophagy blocks cathepsins-tBid-mitochondrial apoptotic signaling pathway via stabilization of lysosomal membrane in ischemic astrocytes.Targeting astrocytes for stroke therapy.Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases.Neuroprotection targeting ischemic penumbra and beyond for the treatment of ischemic stroke.The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseasesPeriodic Estrogen Receptor-Beta Activation: A Novel Approach to Prevent Ischemic Brain Damage.Erythropoietin exerts cell protective effect by activating PI3K/Akt and MAPK pathways in C6 Cells.
P2860
Q26781557-BD8E18FB-52A4-4454-B994-D3C7D964D25DQ27692601-A0C7697B-C4E0-4C82-9767-3A85F30A9801Q28240807-2FD966B8-855A-4184-B1A8-77F811E47B50Q28575123-FC54F770-D870-4CDB-974A-155FD1F22554Q29615839-422BA7A7-C673-4CA1-A7A7-7AC70C159104Q33632272-FBF57D1E-18A7-43F1-9E78-0D8A1CDA5BE9Q33718009-A4709FE5-8A08-4081-8292-1FFD4FF01B95Q33729382-BA751F00-2823-44E5-BB04-A160D7C8303BQ33823616-FD3EB976-AF90-4281-88A7-5C1D0F2E08FDQ34534371-F6D2EE9D-FFEE-4C62-A1D0-7A1DBC00478DQ34621267-5635C9AC-E920-4E13-A253-04323E5C318CQ34774194-CCA37557-8EBA-4CE1-9E46-999C66A6DC1BQ35001946-DAFFBC06-E96E-4B05-A867-86B7560E3616Q35043454-F3489845-DEF4-4CDE-B3B3-790EF22E3A9EQ35060288-9682F943-AF95-45C1-B57F-3238FA9D25DEQ35123810-5D49AE0F-6CAB-497D-AD36-1725DF7232D0Q35559895-95727324-0CAE-4942-B768-49B8BF284954Q36040693-F55A583F-A956-4516-ADEE-1B3099CAA380Q36124038-C9BDC8BC-91AC-4B89-8820-6954185E4A82Q36136728-6E181494-1945-4302-AF80-9A3C15760142Q36330297-539D84C2-C5D1-45BC-9F73-C8A0DA559F01Q36354157-EDB3B283-A70F-4D5E-BAFF-9BDA917A68CDQ36379329-F00DAF0E-322E-4DF1-9EB0-10DA788C485CQ36415643-0FC69755-4AD9-4B0E-88CF-4888794D2413Q36575843-481CCFF9-0D25-4D2B-8D73-E434CA564F16Q36576391-2CAF5473-FF7D-42B1-8565-1FF551A57811Q36901553-E7549B91-7D92-4C43-836E-718F71003638Q36953709-6F121D3C-0860-42B6-9802-D624A8EE8077Q37046010-EDE70112-BECF-4C51-95BD-980CE46F0B62Q37212029-D48E8045-55E4-4CD9-A018-2F3019702A82Q37361396-655EB0E0-91AE-454B-9D22-E9275034DF15Q37607937-BD457C25-7DCE-4CB1-B11A-E3F675E48412Q37652820-AA838282-2228-468D-AAEB-9FFA4F832FF0Q37745228-4FF04475-D871-4B96-B156-7C3F24F0D228Q37794392-22702DEC-1217-4AD7-B657-A3663856C8ABQ37890058-EAA512FD-19B3-48E2-85A1-932B4CED1420Q38014162-47D9964F-7E7D-405C-8F2A-F3DB55B08DC0Q38157892-2B4127A9-0D24-4F27-BED0-5607EFA10EA1Q38218301-99630352-6F2E-49CD-A557-EE9F6AFE677CQ39025465-74ED338B-7341-45C2-9D7E-B479874EEC25
P2860
Dysfunctional cell-cell signaling in the neurovascular unit as a paradigm for central nervous system disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dysfunctional cell-cell signal ...... entral nervous system disease.
@en
Dysfunctional cell-cell signal ...... entral nervous system disease.
@nl
type
label
Dysfunctional cell-cell signal ...... entral nervous system disease.
@en
Dysfunctional cell-cell signal ...... entral nervous system disease.
@nl
prefLabel
Dysfunctional cell-cell signal ...... entral nervous system disease.
@en
Dysfunctional cell-cell signal ...... entral nervous system disease.
@nl
P2860
P1433
P1476
Dysfunctional cell-cell signal ...... entral nervous system disease.
@en
P2093
P2860
P356
10.1161/STROKEAHA.108.534388
P407
P433
P577
2008-12-08T00:00:00Z